Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends
XTalks
AUGUST 2, 2023
It also has a significant presence in consumer health sectors such as dermatology, nutritionals and allergy. This growth was propelled by the expansion of its development portfolio in cell and gene therapies, as well as advancements in late-stage pharmaceutical pipeline drugs like asundexian and elinzanetant. billion JPY ($1.51
Let's personalize your content